We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRAH
376
DELISTED
PRA Health Sciences, Inc.
PRAH
| $4.43M | 0.06% |
43,705
+10,404
| +31% | +$1.06M |
|
377
Abercrombie & Fitch
ANF
$4.17B
| $4.42M | 0.06% |
+317,164
| New | +$3.7M |
|
378
Trimble
TRMB
$12.3B
| $4.4M | 0.06% |
+90,329
| New | +$4.32M |
|
|
GLUU
379
DELISTED
Glu Mobile Inc.
GLUU
| $4.39M | 0.06% |
571,463
+440,129
| +335% | +$3.7M |
|
380
Fastenal
FAST
$54B
| $4.35M | 0.06% |
+193,086
| New | +$4.44M |
|
381
NXP Semiconductors
NXPI
$68B
| $4.33M | 0.06% |
34,682
-12,770
| -27% | -$1.56M |
|
382
Jazz Pharmaceuticals
JAZZ
$15.9B
| $4.31M | 0.06% |
30,225
-43,438
| -59% | -$5.39M |
|
383
Arch Capital
ACGL
$36.1B
| $4.31M | 0.06% |
147,215
+70,574
| +92% | +$2.15M |
|
384
Sabre
SABR
$656M
| $4.3M | 0.06% |
660,265
+68,547
| +12% | +$508K |
|
|
BNY
385
Bank of New York Mellon
BNY
$108B
| $4.29M | 0.06% |
124,924
-92,333
| -42% | -$3.36M |
|
|
EXAS
386
DELISTED
Exact Sciences
EXAS
| $4.26M | 0.06% |
41,796
-45,602
| -52% | -$3.94M |
|
387
HP
HPQ
$23.5B
| $4.24M | 0.06% |
+223,300
| New | +$4.07M |
|
388
Atmos Energy
ATO
$29.9B
| $4.24M | 0.06% |
44,316
+5,216
| +13% | +$521K |
|
389
MSCI
MSCI
$40B
| $4.22M | 0.06% |
11,830
+9,980
| +539% | +$3.62M |
|
390
Pilgrim's Pride
PPC
$6.82B
| $4.18M | 0.06% |
279,669
+116,522
| +71% | +$1.86M |
|
391
Lockheed Martin
LMT
$134B
| $4.18M | 0.06% |
10,909
-34,431
| -76% | -$13.1M |
|
392
Federated Hermes
FHI
$4.4B
| $4.14M | 0.06% |
192,344
-81,125
| -30% | -$1.92M |
|
393
NetApp
NTAP
$32.9B
| $4.13M | 0.06% |
94,310
-97,390
| -51% | -$4.25M |
|
394
Crocs
CROX
$6.69B
| $4.13M | 0.06% |
96,744
+31,891
| +49% | +$1.23M |
|
|
OSH
395
DELISTED
Oak Street Health, Inc.
OSH
| $4.12M | 0.06% |
+77,017
| New | +$3.45M |
|
396
Yeti Holdings
YETI
$3.82B
| $4.12M | 0.06% |
+90,798
| New | +$4.3M |
|
397
Hanover Insurance
THG
$7.63B
| $4.11M | 0.06% |
44,156
+7,112
| +19% | +$706K |
|
398
ScottsMiracle-Gro
SMG
$4.03B
| $4.11M | 0.06% |
26,852
+3,460
| +15% | +$535K |
|
399
Interactive Brokers
IBKR
$40.9B
| $4.06M | 0.05% |
335,896
-24,916
| -7% | -$311K |
|
400
Republic Services
RSG
$66.7B
| $4.05M | 0.05% |
43,443
-185,172
| -81% | -$16.6M |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.